EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

AAV-mediated gene therapy as an efficient treatment strategy in fucosidosis mice

Svenja Jelinek, Hannah Bäumges, Claire Rothschild-Gronau, Hans Christian Beck, Rebecca Christine Feiner, Mai-Britt Ilse, Kristian Mark Müller, Torben Lübke

Molecular Therapy Advances · 2026-11 · 201884

DOI: 10.1016/j.omta.2026.201884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-11. Verfasst von Svenja Jelinek und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jelinek, S., Bäumges, H., Rothschild-Gronau, C., Beck, H. C., Feiner, R. C., Ilse, M., Müller, K. M., & Lübke, T. (2026). AAV-mediated gene therapy as an efficient treatment strategy in fucosidosis mice. Molecular Therapy Advances, 201884. https://doi.org/10.1016/j.omta.2026.201884

Vancouver

Jelinek S, Bäumges H, Rothschild-Gronau C, Beck HC, Feiner RC, Ilse M, et al. AAV-mediated gene therapy as an efficient treatment strategy in fucosidosis mice. Molecular Therapy Advances. 2026:201884. doi:10.1016/j.omta.2026.201884

BibTeX
@article{Jelinek2026,
  author = {Jelinek, Svenja and Bäumges, Hannah and Rothschild-Gronau, Claire and Beck, Hans Christian and Feiner, Rebecca Christine and Ilse, Mai-Britt and Müller, Kristian Mark and Lübke, Torben},
  title = {AAV-mediated gene therapy as an efficient treatment strategy in fucosidosis mice},
  journal = {Molecular Therapy Advances},
  year = {2026},
  pages = {201884},
  doi = {10.1016/j.omta.2026.201884}
}
Kostenlos starten →